Oxford Medical Diagnostics and Michell Instruments launch gas analysis partnership
Oxford Medical Diagnostics and Michell Instruments will jointly develop new industrial gas detection and measurement devices for a number of industrial applications
Oxford Medical Diagnostics (OMD and Michell Instruments (MI) announced a new partnership aimed at pioneering advanced laser absorption spectroscopy applications in industrial gas detection and analysis.
Under the terms of the agreement, the two companies will focus on the targeting, design and pre-commercial development of new industrial gas detection and measurement devices for various industrial purposes, using optical, acoustic, plasma emission and related spectroscopic technologies. OMD will be responsible for the design and the development, in partnership with Michell, who will be focusing on the commercialization. The partners may also involve further third parties in the future.
The new devices will integrate OMD’s proprietary technologies such as Cavity Enhanced Absorption Spectroscopy (CEAS), Broadband Cavity Enhanced Absorption Spectroscopy (BBCEAS) and Plasma Emission Spectroscopy (PES), besides various non-proprietary technologies. The companies expect the first devices to be in the market in 2012.
Key industrial applications will include the detection of water in natural gas and other commercially important gases, as well as the measurement of environmentally damaging pollutants in the oil and gas industry.
“This is another exciting partnership for Oxford Medical Diagnostics, working alongside one of the global leaders in sensory and measurement solutions,” said OMD’s CEO, Tony Marchington. “In addition to bringing us significant revenues as we develop the company, the partnership allows us to expand our existing gas analysis and detection technologies to new markets and new industrial applications, without diverting us from our core mission of delivering breath diagnostic solutions.”
“The co-operation with OMD is a great opportunity for Michell Instruments to further innovate leading gas analysis technologies, enabling us to provide an improved level of service to our customers,” said Mike Bannister, CEO of Michell Instruments.
Financial terms of the agreement were not disclosed.
- 1Detect neurodegenerative diseases such as Alzheimer's by a simple eye scan?
- 2Fluorescence microscopy at highest spatial and temporal resolution
- 3The Mechanics of the Immune System
- 4Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis
- 5Quick look under the skin
- 6New ion trap to create the world's most accurate mass spectrometer
- 7How does your computer smell?
- 8Clocking electron movements inside an atom
- 9Sartorius closes 2020 with strong growth
- 10A clear path to better insights into biomolecules
- Many researchers are familiar with the problem: Before there are any new fin ...
- oncgnostics cooperates with the Medical University of Graz
- NanoTemper Technologies teams up with PharmAI to help researchers spot game- ...
- Lab supplies out of the 3D printer
- Waters Collaborates with Dr. Sunghwan Kim of Kyungpook National University t ...
- A new way of rapidly counting and identifying viruses
- Malvern Panalytical and Concept Life Sciences announce integration
- First images of cells exposed to COVID-19 vaccine reveal native-like Coronavirus spikes
- Simple, non-invasive skin swab samples are enough to quickly detect COVID-19
- Formation of quadruple helix DNA tracked in live human cells for the first time